Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations
Advances in Nutrition · 2026
DOI: 10.1016/j.advnut.2025.100583 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Nutrition, 2026. Verfasst von Steven A Abrams und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States. Electronic address: sabrams@austin.utexas.edu. Hauptthemen laut MEDLINE: Infant Formula, Nutrition Policy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cattlemen's Beef Association.
Abstract (Originalsprache)
Operation Stork Speed, launched by the Food and Drug Administration in March 2025, represents a comprehensive initiative to update infant formula regulations that have remained largely unchanged since the 1980s. This expert panel review addresses recommendations for nutrients considering 4 decades of accumulated scientific evidence. Current Food and Drug Administration fatty acid regulations specify only total fat content and minimum linoleic acid requirements, despite substantial international consensus on polyunsaturated fatty acid specifications. Evidence strongly supports establishing maximum linoleic acid concentrations and docosahexaenoic acid and arachidonic acid requirements, reflecting the critical role of omega-3 (ω-3) fatty acids in neurocognitive development and visual acuity. The panel emphasizes that saturated and monounsaturated fatty acids comprise over 80% of human milk fatty acids, while acknowledging recent concerns about seed oils and supporting balanced PUFA formulations. Carbohydrate composition presents significant concerns, as over half of United States formulas contain glucose polymers (e.g., corn syrup solids) despite lactose being the primary carbohydrate energy source in human milk. Observational studies have linked corn syrup-based formulas to multiple potential health risks, including excess weight gain, warranting reconsideration of the value of non-lactose carbohydrate substitutions in formulas for healthy children. Protein content recommendations support decreasing the upper range of allowable intake, aligning with European standards and addressing concerns about excessive protein intake contributing to later obesity risk. Micronutrient evaluation reveals the need to reduce the iron content in routine formulas, consistent with European Food Safety Authority recommendations and emerging safety data, and a need to set upper limits for the concentration of calcium and phosphorus. Overall, infant formula is a healthy product that has been successfully feeding infants for many decades. These comprehensive updates aim to more closely align United States infant formula regulations with current scientific understanding and international standards while supporting optimal infant growth, development, and long-term health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States. Electronic address: sabrams@austin.utexas.edu.
- Department of Pediatrics, Dell Medical School at the University of Texas, Austin, TX, United States.
- Department of Regulatory and Quality Sciences, University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.
- Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
- Division of Gastroenterology, Hepatology, and Nutrition, Center for Nutrition, Boston Children's Hospital, Boston, MA, United States.
- Clinical Nutrition, Stanford Medicine Children's Health, Palo Alto, CA, United States.
Förderung
- National Cattlemen's Beef Association
Zitieren
APA
Abrams, S. A., Brenna, J. T., Clemens, R., Cohran, V. C., Du, N., Gilbaugh, A., Goran, M. I., Guild, A., Kerner, J. A., Knudsen, T. B., Krishna, S., & Sentongo, T. (2026). Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations. Advances in Nutrition. https://doi.org/10.1016/j.advnut.2025.100583
Vancouver
Abrams SA, Brenna JT, Clemens R, Cohran VC, Du N, Gilbaugh A, et al. Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations. Advances in Nutrition. 2026. doi:10.1016/j.advnut.2025.100583
BibTeX
@article{Abrams2026,
author = {Abrams, Steven A and Brenna, James Thomas and Clemens, Roger and Cohran, Valeria C and Du, Nan and Gilbaugh, Andrea and Goran, Michael I and Guild, Analeise and Kerner, John A and Knudsen, Thomas B and Krishna, Sushma and Sentongo, Timothy},
title = {Food and Drug Administration Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations},
journal = {Advances in Nutrition},
year = {2026},
doi = {10.1016/j.advnut.2025.100583}
}
EUVIMED